header logo image


Page 531«..1020..530531532533..540550..»

Coronavirus daily news updates, June 9: What to know today about COVID-19 in the Seattle area, Washington state and the world – Seattle Times

June 10th, 2020 6:52 pm

Editors note:This is a live account of COVID-19 updates fromTuesday,June 9,as the day unfolded. Click here to see updates from Wednesday, June 10.Tofind resources and the latest extended coverage of the pandemic,click here.

Across the country and around the world, more people are forgoing physical distancing. Its not just the George Floyd protests, which have drawn floods of demonstrators economies are starting to reopen and people are inching back toward their normal routines.

Meanwhile, the protests continue, and medical experts reiterate their warnings that tear gas and pepper spray can increase the spread of respiratory viruses.Local businesses in Washington face unprecedented financial challenges as theystruggle to recover from both the effects of the pandemic and recent looting, although many owners of the hardest-hit businesses have been quick to voice support for the protests.

Throughout Tuesday, on this page, well post updates from Seattle Times journalists and others on the pandemic and its effects on the Seattle area, the Pacific Northwest and the world. Updates from Monday can be foundhere, and all our coronavirus coveragecan be found here.

The following graphic includes the most recent numbers from the Washington State Department of Health, released Tuesday.

The agonizing tale of the coronavirus outbreak on the carrier USS Theodore Roosevelt starting in March led to the infection of hundreds of crew members, an emergency stop in Guam, the removal of the ships captain and the resignation of the acting Navy secretary.

But while the Navy and civic leaders in Guam struggled to quell the spread of the virus, naval officials and researchers at the Centers for Disease Control and Prevention began a medical investigation into the outbreak, the results of which were released Tuesday.

The study found that, among a few hundred service members who volunteered to be tested and questioned about their experiences onboard and while in Guam, more than a third had enough functioning antibodies to the coronavirus to indicate they could have some protection against the virus, at least for a limited time.

Some were still showing the presence of neutralizing antibodies, which block the virus from binding to cells, three months after the onset of symptoms.

The New York Times

The coronavirus pandemic has caused most rents in the Seattle area to stagnate,though theyre falling for the least-expensive apartments, according to data from analytics firm RealPage.One neighborhood West Seattle is seeing especially sharp cuts, according to landlords and property managers, thoughnotjust from the pandemic.

Overall, in the Seattle-Bellevue-Everett area, May asking rentswere nearly the same as they were a year ago, averagingjust under $1,900, whereas before the pandemic, rents were up nearly 5% year-over-year in the area.RealPage looks at effective asking rents, which include advertised discounts offered by landlords and property managers to entice new tenants to ink a deal, like one month of free rent.

The bigslide has beenamong the least-expensive properties, where May asking rents were off 0.8% compared with a year earlier, to an average of $1,518. Rents for apartments near Boeing offices and factories in Renton and Everett were also down, by as much as 3.1%. The company recently announcedcuts of almost 10,000 jobs in Washington state.

Still, even national landlords with huge luxury portfolios are sweeteningdeals to close contracts. Astatewide eviction moratorium and ban on rent increases have keptarea renters in their apartments and slowed demand.

Read the full story here.

Katherine K. Long

King County and other local organizations announced Tuesday they're planning to partner with free coronavirus-testing campaigns led by Beyonc and her mother, Tina Knowles Lawson.

The partnership a part of Knowles Lawson's#IDIDMYPART campaign and Beyoncs BeyGood initiative will provide two days of free drive-thru COVID-19 testing in South King County cities, "where Black and brown communities are suffering disproportionately from coronavirus," said a statement from the county.

Attendees will also receive community care packages, diapers and toiletries for free.

I could not be prouder and elated that organizations in King County, Washington, stepped up in such a responsible way, Knowles Lawson said in the statement. It is imperative that we remember during these difficult times, when we are fighting for social justice, that we are also in a pandemic that is killing people at an alarming rate. We are dealing with two diseases that are disproportionately ravaging the Black community; COVID-19 and racism. We have to do all we can to combat both.

The first day of free testing will take place on June 13 from 11 a.m. to 5 p.m. atHealthPoint Administration at 955 Powell Ave. Southwest in Renton. The second day will take place June 14 from 11 a.m. to 5 p.m. at Sea Mar Community Health Medical Centerat 31405 18th Ave. South in Federal Way.

Weve always known that Black and brown communities face barriers to quality healthcare compared to white communities, said Hamdi Mohamed, King County policy advisor for the Executive Office of Equity and Social Justice, in the statement. We see it in high maternal mortality rates for Black women, we see it in disproportionately high populations of uninsured people in communities of color, and we see it now in the COVID-19 crisis, as people of color are being affected at a rate nearly two-and-a-half times higher than that of whites."

More information about the testing is available here.

Elise Takahama

In negotiations with players to resume a season shut down by the coronavirus pandemic, Major League Baseball is administering self-inflicted wounds from which it might never fully recover, no matter how tight the pennant races or majestic the play, Seattle Times sports columnist Larry Stone writes.

Stone, a lifelong baseball fanatic, has reflexively fought back against criticism of the sport over the years. "But," he writes, "youre on your own this time, fellas."

Read Stone's full column here.

U.S. Rep. Pramila Jayapal, D-Seattle, and at least 14 other Democratic members of Congress planned to ask a court to require greater COVID-19 safety measures at an Amazon warehouse in New York, in a legal brief supporting workers who sued the company last week.

Employees at Amazons Staten Island distribution center known as JFK8 alleged in the suit that the company did not adequately inform them of disease outbreaks in the facility and maintained oppressive productivity requirements, among other conditions that contributed to the spread of COVID-19 and the death of one of the plaintiffs family members.

The lawmakers urged the judge to issue an emergency injunction under New York state labor law and common law, citing inaction by federal workplace safety regulators and noting their own legislative efforts will take time to enact and implement.

Read the full story here.

Benjamin Romano

Around the world, in varying stages, people are cautiouslyventuring out to shop, eat, vote, protest and more.

See more images from today of a world coping with a new version of daily life.

Courtney Riffkin

Herd immunity is when a virus can no longer spread easily because enough people are immune to it. That lowers the chances of the virus jumping from person to person and reaching those who havent been infected yet.

People can become immune to certain viruses after surviving infection or being vaccinated. Typically, at least 70% of a population must be immune to achieve herd immunity. But how long immunity lasts varies depending on the virus, and its not yet known how long COVID-19 survivors might have that protection.

Here's what to know about herd immunity and whether it could work with COVID-19.

The Associated Press

The Vienna Philharmonic returned home, and its famous strings purred for the first time since March 10.

Its 2,854-seat Musikverein, considered by many the worlds most beautiful concert hall, was filled with only 100 people Friday for the first of three days of programs with Daniel Barenboim. Because of the negligible number, tickets were distributed to family, friends and donors for among the first performances by a major orchestra since the pandemic paused the season.

The three-month gap was difficult for members of the orchestra, which is considered in the music world to rank among the best.

Even if we are not allowed to play a concert, we want to do some recordings or just to play for ourselves, because we are quite convinced that we need to play as an orchestra, said DanielFroschauer, a first violinist and the orchestra chairman. The best soccer teams like Real Madrid, they have to play together.

Read the full story here.

The Associated Press

OLYMPIA Gov. Jay Inslee has extended through Aug. 1 an emergency proclamation intended to protect workers at high risk of COVID-19 from losing their jobs or income.

The order applies to workers 65 or older, as well as people of any age with underlying conditions that could put them at risk if they got infected with the virus.

Among other things, the order bars employers from permanently replacing high-risk workers.

It mandates that high-risk workers be given a choice of alternative work settings, such as working remotely.

High-risk workers can also use leave they've accrued or unemployment benefits if an alternate work assignment isnt feasible and the employee cant safely work.

Joseph O'Sullivan

State health officials confirmed 313 new COVID-19 cases in Washington on Tuesday, as well as 15 additional deaths.

The update brings the states totals to 24,354 cases and 1,176 deaths, according tothe state Department of Healths (DOH) data dashboard. The dashboard reports 3,747 people hospitalized in Washington.

So far, 415,054 tests for the novel coronavirus have been conducted in the state, per DOH. Of those, 5.9% have come back positive.

King County, the state's most populous, has reported 8,529 positive test results and 580 deaths, accounting for a little less than half of the state's death toll.

Scott Greenstone

The coronavirus pandemic continues to rage in Yakima County, with the total number of cases closing in on 5,000.

The Yakima Health District reported 215 more infections Monday, bringing the total of confirmed cases to 4,929.

The Yakima Herald-Republic reported deaths from COVID-19 remained at 96.

We are a hot spot for COVID-19, health district spokeswoman Lilian Bravo said.

Read the story here.

The Associated Press

The World Health Organization walked back its comments that asymptomatic people rarely spread the new coronavirus.

Less than 24 hours after Dr. Maria Van Kerkhove, the head of the WHO's emerging disease and zoonosis unit, said that asymptomatic transmission was "very rare" in response to a journalist's question the organization held a press conference Tuesday morning to clarify its position.

But the comment from Monday had already spread widely and been seized upon by conservatives and others to bolster arguments that people do not need to wear masks or maintain social distancing precautions.

The episode sparked criticism of WHOs public health messaging and highlighted just how fraught and easily politicized such work remains months into the pandemic.

I wasnt stating a policy of WHO or anything like that, Kerkhove said. We do know that some people who are asymptomatic, or some people who do not have symptoms, can transmit the virus on.

It was not the intent of WHO to say there is a new or different policy, added Mike Ryan, head of emergency programs for WHO. There is still too much unknown about this virus and still too much unknown about its transmission dynamics.

While asymptomatic transmission does occur, no one knows for sure how frequently that happens. Studies and models have suggested many of those infected never show symptoms. And it remains an open question whether they are a large force driving transmission. At the same time, however, some countries using contact tracing to work backward from confirmed cases have not found many instances of asymptomatic spread, WHO officials noted.

Full story here.

The Washington Post

Moscow emerged from a strict lockdown Tuesday with the city government citing a slowdown in the coronavirus outbreak and critics expressing concerns over the potential for a new wave of infections in the Russian capital.

As of Tuesday, Moscow residents are no longer required to stay at home or obtain electronic passes for traveling around the city, Mayor Sergei Sobyanin said Monday. All restrictions on taking walks, using public transportation or driving have been lifted as well.

The sudden ending of restrictions imposed in late March comes weeks before a nationwide vote on a constitutional change that would allow President Vladimir Putin to stay in power until 2036 and was condemned by Kremlin critics as premature and politically motivated.

The lifted lockdown measures not only permitted Moscow residents to move about, but allowed beauty parlors to reopen Tuesday. Outdoor terraces of cafes and restaurants, as well as museums and dental clinics, are set to open on June 16. Kindergartens, gyms and indoor spaces of cafes and restaurants will be allowed to operate starting June 23.

The fight isnt over yet, Sobyanin said in a video address Monday. Nevertheless, I would like to congratulate you on our common victory and a big step towards returning to a full-fledged life.

Read the story here.

The Associated Press

The British government on Tuesday backed away from plans to have all primary school children return to school in England before the summer holidays, following concerns by principals that they could not meet coronavirus social distancing requirements if everyone returned.

Education Secretary Gavin Williamson admitted that the goal for Englands approximately 5 million primary schoolchildren from age 4 to 11 was not possible, given constraints related to classroom sizes, the need for social distancing and inadequate numbers of teachers.

While we are not able to welcome all primary children back for a full month before the summer, we continue to work with the sector on the next steps, Williamson told lawmakers.

Although many of Englands primary schools have been open this entire spring for the children of key workers including health care professionals, delivery drivers and journalists the Conservative government had planned to get all younger children back in stages. Britains school year normally runs until late July.

Read the story here.

The Associated Press

An indicator of new business starts is running ahead of last years pace at the national level, though in Washington state it still trails.

According to the Census Bureau, applications for new tax IDs, which it considers a sign of new business formation, have turned upward in recent weeks.

When calculated as a rolling average over four weeks, the U.S. figure now surpasses the level at this time last year. Washington state has been slower to relax restrictions imposed because of the coronavirus pandemic, and new business formation has been slower to recover.

For more charts on the coronavirus economy and other economic news, click here.

Rami Grunbaum

For the past few weeks, the United States has been wrestling through two tough conversations with itself about two pandemics though the volume got turned way up on the one about racism and health care workers, particularly those of color, are living in the middle of both.

Racism is the biggest public health crisis of our time, one Black surgeon at UW explained during a recent march.

Read the full story here.

Brendan Kiley

Washington state health officials confirmed 312 new COVID-19 cases yesterday. Globally, the pandemic is worsening, with countries on Sunday reporting the biggest-ever one-day total of cases. Track the spread of the virus here.

"We need to get open, because were hemorrhaging cash." Seattle-area small businesses are facing unprecedented challenges, staggered first by coronavirus closures, then by looting.

Here come the masks, Washington hopes. A federal agency's approval of a coveted N95 mask from China paves the way for the state to complete its huge order.

The shutdowns prevented about 60 million coronavirus infections in the U.S, researchers say, and easing them brings new risks. As Washington state creaks back open again, here's our county-by-county guide to what you can do, from haircuts to horse races.

You can go to Canada ... if you're family. The country is easing border restrictions a bit, but requiring a quarantine period.

Kris Higginson

View post:
Coronavirus daily news updates, June 9: What to know today about COVID-19 in the Seattle area, Washington state and the world - Seattle Times

Read More...

Metal Fiducial Marks Market Emerging Trends, Strong Application Scope, Size, Status, Analysis and Forecast to 2025 – Cole of Duty

June 10th, 2020 6:51 pm

A recent research on Metal Fiducial Marks market, now available with Market Study Report, LLC, is a thorough study on the latest market trends prevailing in the global business sphere. The report also offers important details pertaining to market share, market size, profit estimations, applications and statistics of this industry. The report further presents a detailed competitive analysis including growth strategies adopted by key players of the industry.

.

Request a sample Report of Metal Fiducial Marks Market at:https://www.marketstudyreport.com/request-a-sample/2623520?utm_source=coleofduty.com/&utm_medium=VSD

The Metal Fiducial Marks market report is a thorough analysis of this industry vertical. The report predicts the renumeration and growth rate over the forecast timeline. It also elaborates on the key aspects of Metal Fiducial Marks market including market size, industry share held by various regions, and sales accrued by different product segments. An elaborate representation of growth indicators and challenges of this industry vertical is also entailed in the report.

Understanding the Metal Fiducial Marks market with respect to the geographical landscape:

Ask for Discount on Metal Fiducial Marks Market Report at:https://www.marketstudyreport.com/check-for-discount/2623520?utm_source=coleofduty.com/&utm_medium=VSD

Other takeaways of the Metal Fiducial Marks market report are listed below:

.

.

.

For More Details On this Report: https://www.marketstudyreport.com/reports/global-metal-fiducial-marks-market-2020-by-manufacturers-regions-type-and-application-forecast-to-2025

Some of the Major Highlights of TOC covers:

Metal Fiducial Marks Regional Market Analysis

Metal Fiducial Marks Segment Market Analysis (by Type)

Metal Fiducial Marks Segment Market Analysis (by Application)

Metal Fiducial Marks Major Manufacturers Analysis

Related Reports:

1. Global Stem Cells Cryopreservation Equipment Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025This report categorizes the Stem Cells Cryopreservation Equipment market data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors Analysis.Read More: https://www.marketstudyreport.com/reports/global-stem-cells-cryopreservation-equipment-market-2020-by-manufacturers-regions-type-and-application-forecast-to-2025

2. Global Dental High-speed Handpiece Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025Dental High-speed Handpiece Market report covers the market landscape and its growth prospects over the coming years, the Report also brief deals with the product life cycle, comparing it to the relevant products from across industries that had already been commercialized details the potential for various applications, discussing about recent product innovations and gives an overview on potential regional market.Read More: https://www.marketstudyreport.com/reports/global-dental-high-speed-handpiece-market-2020-by-manufacturers-regions-type-and-application-forecast-to-2025

Related Report : https://www.marketwatch.com/press-release/topical-pain-relievers-market-by-size-growth-opportunity-and-forecast-to-2025-2020-06-06

Contact Us:Corporate Sales,Market Study Report LLCPhone: 1-302-273-0910Toll Free: 1-866-764-2150 Email: [emailprotected]

See more here:
Metal Fiducial Marks Market Emerging Trends, Strong Application Scope, Size, Status, Analysis and Forecast to 2025 - Cole of Duty

Read More...

Patient uses fat stem cells to repair his wrist – CNN

June 10th, 2020 6:49 pm

He was tired of the daily pain that made even shaking someone's hand almost unbearable.

Marlette lost his arm in an accident when he was a teenager, but as an active kid, he didn't this slow him down. He continued to play football and golf, running track and even wrestling.

But over time, the strain on his remaining arm and wrist took a toll.

So to relieve his pain, he traveled from Sioux Falls, South Dakota, to Munich, Germany, with the hopes that a special procedure using stem cells could make a difference.

"There's no cartilage," Marlette said of his wrist. "I'm bone-on-bone. It is constantly inflamed and very sore."

As Marlette grew older, even the simplest things, like tucking in his shirt or putting on a jacket, became incredibly painful.

Regenerating hope

Marlette developed cysts and holes in the bones of his wrist. Doctors prescribed anti-inflammatory medications, but they only managed the pain, doing nothing to actually heal the problem. One day, his doctor, Dr. Bob Van Demark at Sanford Health in South Dakota, where Marlette works in finance, saw a presentation by Dr. Eckhard Alt.

It was about a new treatment using stem cells.

"Following an infection or wound or trauma," Alt said, "there comes a call to the stem cells in the blood vessels, which are silent, and nature activates those cells."

Stem cells are located throughout our bodies, like a reserve army offering regeneration and repair. When we're injured or sick, our stem cells divide and create new cells to replace those that are damaged or killed. Depending on where the cells are in the body, they adapt, becoming specialized as blood cells, muscle cells or brain cells, for example.

Alt was the first person to use adipose tissue, or fat, as a prime source of stem cells, according to Dr. David Pearce, executive vice president for research at Sanford health.

"He observed that the simplest place to get some stem cells is really from the fat," said Pearce. "Most of us could give some fat up, and those stem cells don't have to be programmed in any way, but if you put in the right environment, they will naturally turn into what the cell type around them is."

Fat tissue has a lot of blood vessels, making it a prime source of stem cells, and Alt recognized that stem cells derived from adipose tissue are also particularly good at becoming cartilage and bone.

Bone marrow is another source of stem cells, but these easily turn into blood and immune cells. Stem cells from fat have another fate.

"Fat-derived stem cells have a different lineage they can turn into, that is really cartilage and bone and other sort of connective tissues," said Pearce.

Van Demark traveled to Alt's Munich clinic along with some doctors from Sanford, which is now partnering with Alt on clinical trials in the United States. Marlette's doctor was impressed with what he saw and recommended the treatment to his patient.

Marlette paid his own way to Munich, where he would receive an injection of stem cells from his own fat tissue.

"I had one treatment, and my wrist felt better almost within the next couple weeks," Marlette said. "Through the course of the next seven months, it continued to feel better and better."

One injection was enough for this ongoing improvement.

"We see (from an MRI scan) that those cysts are gone, the bone has restructured, the inflammation is gone, and he formed ... new cartilage," said Alt.

MRIs confirmed what he was feeling: The cartilage had begun to regenerate in his wrist. Because the procedure uses autologous cells, which are cells from the patient's own body, there's little to no chance of rejection by the body's immune system.

A controversial past

Though the procedure worked for Marlette, the use of stem cells as a form of treatment is not without controversy or risk. In the US, they have been mired in controversy because much of the early research and discussion has been centered around embryonic and fetal stem cells.

Marlette traveled to Germany because approved treatments like this are not available in the United States. Clinics have popped up across the country, but they lack oversight from the Food and Drug Administration.

Dr. Robin Smith, founder of the Stem for Life Foundation, first began working in this field 10 years ago. According to Smith, there were 400 clinical trials for stem cells when she first started; now, there are 4,500. She partnered with the Vatican to hold a stem cell conference last year.

"We're moving toward a new era in medicine," said Smith, who was not involved in this research. "(We are) recognizing cells in our body and immune system can be used in some way -- manipulated, redirected or changed at the DNA level -- to impact health and cure disease. It is an exciting time."

Dr. Nick Boulis is a neurosurgeon with Emory University in Atlanta. His team ran the first FDA-approved clinical trials in the US to inject stem cells in the spinal cords of patients with ALS, better known as Lou Gehrig's disease, and he isn't surprised to see procedures like the one at Alt's clinic in Germany have success.

"Joints and bones heal," Boulis said. "The nervous system is very bad at healing. It doesn't surprise me that we're seeing successes in recapitulating cartilage before we're seeing successes in rebuilding the motherboard."

Smith also cautioned patients to do their research, especially about the types of cells being used. "When you have a health problem, and you need a solution, sometimes you don't have three five, seven years to get there," she said, referencing the slow progression of regulations in places like the United States.

"So really ,look for places that have the regulatory approval of the country they're in. Safety has to be number one," she said.

Alt's Munich clinic was approved by the European equivalent of the FDA, the European Medicines Agency. Through the partnership with Sanford, the health group is now launching clinical trials in America, focusing on rotator cuff injuries, a common shoulder injury. This is the first FDA-approved trial of its kind.

Further down the line, Alt hopes to see stem cells used for such issues as heart procedures and treating the pancreas to help diabetics. For him, the growth is limitless.

"I think it will be exponential," he said. "It will be the same thing (we saw) with deciphering the human genome. The knowledge will go up exponentially, and the cost will go exponentially down. For me, the most exciting thing is to see how you can help patients that have been desperate for which there was no other option, no hope, and how well they do."

For Marlette, it has meant a wrist free from pain and a life free from pain medication.

Since the procedure in August, he hasn't taken any of the anti-inflammatory drugs. "I have more range of motion with my wrist, shaking hands didn't hurt anymore," he said. "My wrist seems to continue to improve, and there's less and less pain all the time."

More here:
Patient uses fat stem cells to repair his wrist - CNN

Read More...

FDA Warns About Stem Cell Therapies | FDA

June 10th, 2020 6:49 pm

Espaol

Researchers hope stem cells will one day be effective in the treatment of many medical conditions and diseases. But unproven stem cell treatments can be unsafeso get all of the facts if youre considering any treatment.

Stem cells have been called everything from cure-alls to miracle treatments. But dont believe the hype. Some unscrupulous providers offer stem cell products that are both unapproved and unproven. So beware of potentially dangerous proceduresand confirm whats really being offered before you consider any treatment.

The facts: Stem cell therapies may offer the potential to treat diseases or conditions for which few treatments exist. Sometimes called the bodys master cells, stem cells are the cells that develop into blood, brain, bones, and all of the bodys organs. They have the potential to repair, restore, replace, and regenerate cells, and could possibly be used to treat many medical conditions and diseases.

But the U.S. Food and Drug Administration is concerned that some patients seeking cures and remedies are vulnerable to stem cell treatments that are illegal and potentially harmful. And the FDA is increasing its oversight and enforcement to protect people from dishonest and unscrupulous stem cell clinics, while continuing to encourage innovation so that the medical industry can properly harness the potential of stem cell products.

To do your part to stay safe, make sure that any stem cell treatment you are considering is either:

And see the boxed section below for more advice.

The FDA has the authority to regulate stem cell products in the United States.

Today, doctors routinely use stem cells that come from bone marrow or blood in transplant procedures to treat patients with cancer and disorders of the blood and immune system.

With limited exceptions, investigational products must also go through a thorough FDA review process as investigators prepare to determine the safety and effectiveness of products in well-controlled human studies, called clinical trials. The FDA has reviewed many stem cell products for use in these studies.

As part of the FDAs review, investigators must show how each product will be manufactured so the FDA can make sure appropriate steps are being taken to help assure the products safety, purity, and strength (potency). The FDA also requires sufficient data from animal studies to help evaluate any potential risks associated with product use. (You can learn more about clinical trials on the FDAs website.)

That said, some clinics may inappropriately advertise stem cell clinical trials without submitting an IND. Some clinics also may falsely advertise that FDA review and approval of the stem cell therapy is unnecessary. But when clinical trials are not conducted under an IND, it means that the FDA has not reviewed the experimental therapy to help make sure it is reasonably safe. So be cautious about these treatments.

About FDA-approved Products Derived from Stem Cells

The only stem cell-based products that are FDA-approved for use in the United States consist of blood-forming stem cells (hematopoietic progenitor cells) derived from cord blood.

These products are approved for limited use in patients with disorders that affect the body system that is involved in the production of blood (called the hematopoietic system). These FDA-approved stem cell products are listed on the FDA website. Bone marrow also is used for these treatments but is generally not regulated by the FDA for this use.

All medical treatments have benefits and risks. But unproven stem cell therapies can be particularly unsafe.

For instance, attendees at a 2016 FDA public workshop discussed several cases of severe adverse events. One patient became blind due to an injection of stem cells into the eye. Another patient received a spinal cord injection that caused the growth of a spinal tumor.

Other potential safety concerns for unproven treatments include:

Note: Even if stem cells are your own cells, there are still safety risks such as those noted above. In addition, if cells are manipulated after removal, there is a risk of contamination of the cells.

When stem cell products are used in unapproved waysor when they are processed in ways that are more than minimally manipulated, which relates to the nature and degree of processingthe FDA may take (and has already taken) a variety of administrative and judicial actions, including criminal enforcement, depending on the violations involved.

In August 2017, the FDA announced increased enforcement of regulations and oversight of stem cell clinics. To learn more, see the statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA website.

And in March 2017, to further clarify the benefits and risks of stem cell therapy, the FDA published a perspective article in the New England Journal of Medicine.

The FDA will continue to help with the development and licensing of new stem cell therapies where the scientific evidence supports the products safety and effectiveness.

Know that the FDA plays a role in stem cell treatment oversight. You may be told that because these are your cells, the FDA does not need to review or approve the treatment. That is not true.

Stem cell products have the potential to treat many medical conditions and diseases. But for almost all of these products, it is not yet known whether the product has any benefitor if the product is safe to use.

If you're considering treatment in the United States:

If you're considering treatment in another country:

Read more here:
FDA Warns About Stem Cell Therapies | FDA

Read More...

Lunch Forum Reopens: The Woodlands Lunch Forum to Host Longevity and Health Event – Woodlands Online

June 10th, 2020 6:48 pm

Larry Deckerhoff, trusted adviser to companies and entrepreneurs in The Woodlands (Texas), announced the continuation of The Woodlands Lunch Forum Series with a luncheon event scheduled for Friday, 10 July 2020 atAmerigos Grille25250 Grogans Park Drive in The Woodlands. The Forum is scheduled to start at 11:30 AM and last an hour and a half. Mr. Deckerhoff indicated,

The theme of this Lunch Forum is Advanced Health for the New Millennium, Immunotherapy and Rejuvenation Focus on Supercharged Immune Systems During Troubled Times. Among our featured speakers will be Ralph Fucetola JD, President of The Woodlands own Institute for Health Research. He will be joined by two experts in rejuvenation and immunotherapies. The short presentations will leave plenty of time to reconnect and enjoy the extraordinary cuisine at Amerigos Grille.

Interested participants are requested to RSVP to stephen.contreras1@hotmail.com the requested donation of $70.00 includes a three course gourmet lunch. Donations in excess of luncheon value are tax-deductible.

Speakers include: Ralph Fucetola JD President, the Institute for Health Research http://www.InHeRe.org Bill Hayes, NutraSpace http://www.NutraSpace.com Elliot Gorog, Health Matching Accounts http://www.healthmatchingaccounts.com

Read more:
Lunch Forum Reopens: The Woodlands Lunch Forum to Host Longevity and Health Event - Woodlands Online

Read More...

Lunch Forum Series Reopens: The Woodlands Lunch Forum Series to Host Longevity and Health Event July 10th at Amerigo’s Grille – Woodlands Online

June 10th, 2020 6:48 pm

THE WOODLANDS, TX - Larry Deckerhoff, trusted adviser to companies and entrepreneurs in The Woodlands (Texas), announced the continuation of The Woodlands Lunch Forum Series with a luncheon event scheduled for Friday, 10 July 2020 at Amerigos Grille, 25250 Grogans Park Drive in The Woodlands. The Forum is scheduled to start at 11:30 AM and last an hour and a half. Mr. Deckerhoff indicated,

Meet You After the Pandemic Reopening

The theme of this Lunch Forum is Advanced Health for the New Millennium, Immunotherapy and Rejuvenation Focus on Supercharged Immune Systems During Troubled Times. Among our featured speakers will be Ralph Fucetola JD, President of The Woodlands own Institute for Health Research. He will be joined by two experts in rejuvenation and immunotherapies. The short presentations will leave plenty of time to reconnect and enjoy the extraordinary cuisine at Amerigos Grille.

The Institute, which was founded in 1998, and focuses on leading edge, natural and nutritional support for vigorous aging and powerful immunity, announces the reopening of its The Woodlands office.

The Institute President will introduce advanced approaches to health and longevity through the featured speakers who are positioned to inform and enlighten, in cooperation with NutraSpace, Health Matching Accounts and Natural Solutions Foundation.

Interested participants are requested to RSVP to stephen.contreras1@hotmail.com the requested donation of $75.00 includes a three course gourmet lunch. Donations in excess of luncheon value are tax-deductible.

Speakers include: Ralph Fucetola JD President, the Institute for Health Research http://www.InHeRe.org Bill Hayes, NutraSpace http://www.NutraSpace.com Elliot Gorog, Health Matching Accounts http://www.healthmatchingaccounts.com

The President of the Institute concluded:

We look forward to a growing presence in The Woodlands community as our alliances with local and regional companies and researchers continue to mature. Our research interests include areas as diverse as longevity nutrition, immunotherapy and autism retrieval. While we expect that the latest pandemic from China, COVID-19, will be contained, holistic approaches to stimulating natural immunity remain highly relevant and are a significant area of Institute interest.

Here is the original post:
Lunch Forum Series Reopens: The Woodlands Lunch Forum Series to Host Longevity and Health Event July 10th at Amerigo's Grille - Woodlands Online

Read More...

Will long snapper Kam Canaday have the longevity as Greg Warren? – Behind the Steel Curtain

June 10th, 2020 6:48 pm

Part 16 of our 90-part series assuming the roster does not change before we are complete which will break down each player of the Steelers current 90-man roster in alphabetical order. This series will encompass many aspects of each players game and their current role with the team. At the end, Ill give some projected stats as well as their chances to make the 53-man roster.

This time we spotlight Steelers Long Snapper:

Position: LSHeight: 6 4Weight: 245 lbsCollege: Portland StateDraft: UDFA, 2016 (Cardinals)

16 Games played

Expires in 2021

$1,135,00 salary cap number (0.57% of total cap)

$450,000 dead money

$685,000 cap savings if cut

Lock. Believe it or not Canaday actually has some competition heading into camp, linebacker/long snapper Christian Kuntz. That being said, cutting Canaday would set the team back nearly $500k so I highly doubt hes going anywhere unless he completely forgot how to snap the ball.

Hows this for expert analysis, I predict Canaday won't botch a single snap... Long snapping stats are fun... Give me a break...

16 Games played

Kameron Canaday, has been a fine long snapper for the Steelers. The best thing we can say about him is that we haven't had to talk about him since he came to the team in 2017. Much like his predecessor, Greg Warren he has been consistent and low maintenance. You can't ask for anything more from your long snapper.

Ola AdeniyiMarcus AllenTyson AlualuTrajan BandyZach BannerJ.T. BarrettJohn BattleJordan BerrySaeed BlacknallBreon BordersChris BoswellAntoine Brooks Jr.Isaiah BuggsDevin BushDeon Cain

Original post:
Will long snapper Kam Canaday have the longevity as Greg Warren? - Behind the Steel Curtain

Read More...

Aon warns pensions not to over-react to Covid-19 mortality spike – Artemis.bm

June 10th, 2020 6:48 pm

Insurance and reinsurance broker and consultancy Aon has warned UK pension schemes not to over-react to the recent short-term spike in mortality rates in the country, as the impact to longevity risk assumptions may not be as significant as it seems.Aons Risk Settlement Group, which deals with pension risk transfer, including the buy-in and buy-out side as well as longevity reinsurance and longevity swaps, says that overall the longevity markets are continuing to function effectively despite the impacts of COVID-19.

Of course, the Covid-19 coronavirus pandemic has caused a significant spike in excess mortality rates in almost every country affected. In the United Kingdom the increase in excess mortality as a result of the pandemic has been among the highest, with the country perhaps the hardest hit.

Aon does not believe this warrants any significant changes in assumption over the forward-mortality rate at this time, though.

Instead, the broker cautioned UK pension schemes against over-reacting to the elevated short-term mortality data when it comes to setting their long-term mortality assumptions.

Tim Gordon, partner and head of Demographic Horizons in Aons Risk Settlement Group, explained, Were emerging from the initial wave of the global COVID-19 pandemic with no effective vaccine and with some critical aspects still unknown. Some people may therefore assume that life expectancy must have reduced, but this is not necessarily the case.

While there are potential outcomes of this crisis that could reduce life expectancy, including the possible impact of economic recession, there are also potential outcomes that could result in higher life expectancy. These could include increased spending on health and social care, and a potential hardening of the UK to future pandemics.

Pension schemes look closely at mortality rate data, modeling and indications to help in setting their assumptions related to longevity risk exposure and also funding needs.

Decisions related to entering into pension risk transfer are made on these basis, while longevity exposure drives the need for hedging and de-risking solutions to reduce exposure to pensioners living longer than anticipated.

So, with excess mortality rates having spiked due to the Covid-19 pandemic, pensions may be thinking they can reduce their longevity assumption and expect to offset longevity de-risking decisions, but this isnt necessarily the case.

Gordon continued, On top of this, the socio-economic profile of pension schemes means that their liabilities are typically partially insulated from the variations we see in national mortality statistics. Accordingly, it would be premature now to make major changes to best estimate longevity assumptions in either direction. Indeed, it is reasonable for median best estimate assumptions to remain broadly unchanged.

Martin Bird, senior partner and head of Aons Risk Settlement Group, added, Longevity markets have continued to function efficiently over the course of the crisis to date, with bulk annuities and longevity swap transactions continuing apace. Trustees and sponsors have, in our experience, taken the view that risk settlement forms part of their long-term risk management strategy and have been comfortable with proceeding with transactions, despite the turbulence from COVID-19. In fact, in some cases, agile clients have been able to take advantage of pricing opportunities, such as those arising from increased credit spreads earlier in the crisis.

More than ever, it is important for schemes to keep their wits about them when entering a potential transaction. Particular features in the current environment are the need to understand the consequences of different on-risk dates and the potential for regret risk as well as ensuring that investment portfolios are adequately stress-tested to guard against any later liquidity problems.

Reinsurance markets remain open for longevity risk transfer and pension de-risking business at this time, with this area of the market well-capitalised still and likely to continue to be for the foreseeable future.

However, the capital markets still remains ready to assist to a degree and there continues to be appetite for longevity exposure in some life ILS fund strategies.

Read about many historical longevity swap and reinsurance transactions in our Longevity Risk Transfer Deal Directory.

Excerpt from:
Aon warns pensions not to over-react to Covid-19 mortality spike - Artemis.bm

Read More...

Black Winemaker Launches ‘Love-Infused’ Wine After Loss Of Wife – Essence

June 10th, 2020 6:48 pm

Breaking into the wine business is no easy feat especially if youre Black. In fact, there are only approximately 50 black-owned wineries globally, so the journey from winemaker to now president of the Association of African American Vintners was of course met with many challenges.

But none of them could stop Phil Long.

Not even a global pandemic or the loss of his wife and co-founder, Deborah, a year ago to cancer.

Through blood, sweat and tears Long was able to push their dream forward, and fulfill what they started in a garage years ago with the creation of Longevity Wines what he likes to call, a love infused brand. Now with a unique partnership with Bronco Wine Co., the makers of Charles Shaw wines for Trader Joes, Long is able to spread the love and distribute his cabernet sauvignon and chardonnay nationally.

In this interview with ESSENCE, Long shares the inspiration behind his new collection, his hopes for making the wine industry more inclusive and further plans for expansion.

You began your wine journey making wine in the garage with your wife Debra. Because Longevity is defined as a love-infused brand is it inspired by her?

The Longevity brand is absolutely inspired by Debrashe even came up with the name. When I suggested Long Family Cellars, she asked me to look around and tell her what part of our family was helping us make wine? Obviously, the name became Longevity, which is both a play on our last name and a reference to our enduring love for each other and for sharing great wine.

When Deborah and I were dating, I started giving her glass hearts for Valentines Day. Everything in her life became hearts: heart rocks, heart jewelry, heart everything. When we rebranded in 2009, I designed the current label with the intricate heart that contains more hearts along with grapevines and grapes to truly represent who we are. Today, that heart is the icon of our brand and the symbol of our love story.

What makes Longevity stand out against the rest?

Its the heart on the bottle that draws people into our love affair with wine and with each other. Then, they celebrate their own love stories with the delicious wine inside. But its not just about the brand, which has been in many TV shows and movies, its also the fact that this $16 wine competes in the rating arena with wines priced upwards of $50.

What was the creative process behind developing the Longevity collection?

At some point in our journey, we decided that we should have at least one wine named after each family member; that meant one for Debra (Deb-ru-vee), one for me (Phil-osophy) and one for our precious little Havanese pup, PressTon. We still have those three wines on the tasting menu today. They represent no less than 10 different varieties of grapes we use to blend and also to make single varietal wines depending on the quantity available. Those wines have become our signature wines.

What are the changes you feel the wine industry needs to make to be more inclusive?

The fact is African American winemakers make up only one tenth of one percent of the wine industry. In the world of statistics, that rounds down to zero. I think we need to focus on increasing awareness of the fact that African American winemakers do exist and that we produce great wines. Id like to see wineries across the country building a diverse workforce with education programs, internships and scholarships.

Whats one thing about wine that you want to educate Black people on?

In my parents house, there was this tall bottle of Chianti with a basket bowl at the bottom of it. Thats about all I knew about wine growing up. When I went to college, I didnt even know that wine was an industry or a career path. I would like to educate not only African Americans about the world of wine, but all Americans who dont have access to information about this delicacy and its industry. Wine can be a rewarding career.

How do you plan on expanding your company?

Longevity is in the fortunate position to have partnered with Bronco Wine Company to launch our brand nationally. I am now producing California wines on a much larger scale to meet the needs of a national brand. We are still producing our reserve wines in our Livermore Valley facility and every bottle of nationally distributed wine encourages customers to visit our Livermore Valley tasting room.

Continue reading here:
Black Winemaker Launches 'Love-Infused' Wine After Loss Of Wife - Essence

Read More...

pandemic-restrictions-arent-stopping-us-heres-what you need to know – Longevity LIVE

June 10th, 2020 6:48 pm

Pandemic trends show that despite some restrictions many countries are experiencing, were still finding many ways to move. According to Garmin trends data, yes. Most of the worlds daily step count has decreased significantly. However, this is not the whole picture, since many people have developed new routines with different types of exercises to stay active. So just because were experiencing a pandemic, it doesnt mean were sitting on our behind all day.

There has been a massive shift in the way people are moving across the globe. An earlier report by Garmin saw remarkable changes in the types of sports and exercises people were choosing to do. Moreover, Garmin states that simply looking at the step count wont tell a complete story. We know that this number is down in every country, but it doesnt necessarily mean people are exercising less. Think about it. There could be a lady who lives in a tiny flat in Italy, who hasnt been able to walk much at all. But we dont know what shes doing in her flat to keep active. For all we know, she could be cycling indoors for 20km a day. Thats why Garmin has taken this into consideration in their new pandemic trend report. In fact, it could even mean that many people are moving more.

We need to get an accurate picture of how people are moving around the world. Fortunately, Garmins wearable devices can tell us how people are moving, and not just if theyre moving. We do know that the total worldwide steps decreased by 12% in April 2020. However, steps from just workout activities increased by 24%. This means that more people are exercising but in different ways. This makes up for the suppression of normal daily movement during the pandemic.

Its crazy to think that years from today, were going to look back at this pandemic and remember April as the month COVID-19 hit us. Coronavirus extended its debilitating reach to nearly every country, culture, and community on Earth. Theres no denying the fact that the pandemic has impacted our daily lives phenomenally. Besides that, we thought it would be interesting to report back on the effects its having on human activity.

According to the Garmin report, we see a clear reflection of the pandemics crippling global power. Especially when you compare April 2020 to April last year. Aggregated data from millions of Garmin users shows a worldwide decrease of 12% in average daily steps.

Note that Garmin applied a fixed data scale to every country in the world. For this reason, results are magnified for countries with lower population counts and stricter stay-at-home orders. For example, the U.S. compared to Uzbekistan. While Uzbekistan is nowhere near the U.S. in the number of coronavirus cases. It has a bigger percentage decrease because there are fewer people and stricter lockdown rules.

Although the data shows were not walking as much as before, we are moving quite a bit. People are keeping fit during this pandemic, by completing home workouts and other forms of activity to compensate. We cant deny the fact that its certainly become a lot more interesting when it comes to exercise. People are demonstrating a lot of creativity.

We can see that theres a clear reduction in general movement, but when we take a deeper look at the data. Things get a bit more enticing. Garmin reports that a portion of these total worldwide steps come from uploaded activities like running, cycling and hiking. With 20 built-in activity apps on Garmin devices, they were able to accurately detect this data.

This means that if we look at just the steps coming from these logged activities. We can find the opposite trend.On average, steps from logged activities were up 24% worldwide. To sum up, people have started to engage in unique exercise activities to make-up for lost steps in their everyday routines. Not bad for being locked in your home due to a pandemic.

Whether its true, pandemic or not, come hell-high-water, people are getting their exercise in.

The question remains, what is everybody doing to stay fit during the pandemic?

Based on the data, its clear that Garmin users are turning to activities that are most viable depending on their geographic location. Some of these activities are highlighted in our previous post on pandemic trends inthe U.S. and Europe. However, this new data gives us a complete global picture.

The picture below shows activities that saw the largest increase in each country. This is when we compare April 2020 to April 2019.

From what we can see, it seems that most countries have taken to indoor cycling. Apparently, Australians and Canadians both seem to agree that walking is the best activity during life in quarantine. But China, Mexico, South Africa and a handful of other countries have all turned to fitness equipment workouts. But what kind of fitness equipment workouts? Garmin says that indoor cardio accounts for 50% of these workouts. Last year duringDuring the same time period, over 50% of the activities in this category were strength training. Thats very interesting, the pandemic has definitely forced people to make adjustments to their usual routine.

Remember when everybody was raving about strength training? Well, now we have to adapt and look into doing some more cardio too. Moreover, this shift indicates that weve made a shift from gym-structured workouts to home-based find-a-way workouts. Although its evident that a vast majority of people cycle indoors, Garmin took it a step further. They decided to consult a couple of Garmin pro athletes to collect some qualitative context. Interestingly, they said that certain areas like France are not able to cycle outside. says U.S. triathlete Taylor

As a result of the pandemic, many who never did indoor cycling are now doing it five times per week.

The triathlete also said that many athletes are spending more time on platforms like Zwift. He said that their training group meets once every 2 weeks to do a session together. Its a great way to keep yourself motivated to keep moving when having regular virtual sessions. Moreover, its a wonderful way to remain in contact even if it is only once a week. This is particularly important if youre used to meeting regularly with your training group of workout buddies at the gym.

Whilst the pandemic has pushed humanity toward some activities, it has decisively turned it away from others. In a previous article that focused on European trends, it noted that swimming had all but disappeared. As we compare April 2020 to April 2019, this looks to be a global trend too. The data shows significant decreases in swimming activity from the Americas to the Far East.

However, this doesnt mean that swimmers are just sitting all day. The data shows that in Australia 54% of the users who swam in April 2019 are instead running outdoors in April 2020. Then in China, 43% of the users swamin April of last year they were either running or cycling outside this year. In the U.S., pro triathletes are keeping up their fitness by working hard at home. Since most public pools are closed, theyre doing more gym-based strength workouts. If youre a swimmer, then you can even try to replicate some movements and muscle patterns of swimming.

When it comes to multisport training, hiking and golf theres been a massive decrease in multiple countries. But like swimmers, these guys are looking for alternatives. For example, in South Africa, 20% of the users who were golfing in April 2019 turned to indoor fitness workouts in April 2020. And then another 11% began indoor cycling.

The consensus seems to be that people are using this time to their advantage. Particularly if youre an athlete, wed imagine youre using this pandemic to prepare your body for when sports return. Its important to try to maintain your usual activity levels even if it means trying something new.

In conclusion, its obvious that we are finding a way to move no matter what. From the mainstream to a professional athlete, people are adapting routines but clearly not stopping them. If youre a runner but used to enjoy running with your teammates, then try listening to some podcasts or audiobooks while you run. Theres always a way to work around this pandemic.

Hold tight guys, team sports will return eventually. But for now, finding other ways to move on your own is your best bet. Fitness is just one of millions of routine adjustments being made around the world.

Snacking all day, making constant trips to the fridge? Yeah, we totally get where youre coming from.

The Impact of the Global Pandemic on Human Activity: Part III. Garmin. https://www.garmin.com/en-US/blog/fitness/the-impact-of-the-global-pandemic-on-human-activity-part-iii/

The Global Pandemic and Active Lifestyles: Part II. Garmin. https://www.garmin.com/en-US/blog/general/the-global-pandemic-and-active-lifestyles-part-ii/

Continue reading here:
pandemic-restrictions-arent-stopping-us-heres-what you need to know - Longevity LIVE

Read More...

COVID-19 Update: Global Longevity and Anti-senescence Therapy Market is Expected to Grow at a Healthy CAGR with top players CohBar, TA Sciences, Unity…

June 10th, 2020 6:48 pm

Due to the pandemic, we have included a special section on the Impact of COVID 19 on the Longevity and Anti-senescence TherapyMarket which would mention How the Covid-19 is Affecting the Industry, Market Trends and Potential Opportunities in the COVID-19 Landscape, Key Regions and Proposal for Longevity and Anti-senescence Therapy Market Players to battle Covid-19 Impact.

The Longevity and Anti-senescence TherapyMarket report is one of the most comprehensive and important data about business strategies, qualitative and quantitative analysis of Global Market. It offers detailed research and analysis of key aspects of the Longevity and Anti-senescence Therapy market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the Longevity and Anti-senescence Therapy market.

Top Leading players covered in the Longevity and Anti-senescence Therapy market report: CohBar, TA Sciences, Unity Biotechnology, AgeX Therapeutics?Inc, PowerVision Inc. and More

Get PDF Sample Report With Impact of COVID-19 on Longevity and Anti-senescence Therapy [emailprotected] https://www.marketinforeports.com/Market-Reports/Request-Sample/83332

The report offers clear guidelines for players to cement a position of strength in the global Longevity and Anti-senescence Therapy market. It prepares them to face future challenges and take advantage of lucrative opportunities by providing a broad analysis of market conditions. the global Longevity and Anti-senescence Therapy market will showcase a steadyCAGR in the forecast year 2020 to 2024.

Product Type SegmentationHemolytic Drug TherapyGene TherapyImmunotherapyOther Stem Cell Therapies

Industry SegmentationHospitalMedical Service InstitutionDrug and Device Sales

Our Complimentary Sample Longevity and Anti-senescence Therapy market Report Accommodate a Brief Introduction of the research report, TOC, List of Tables and Figures, Competitive Landscape and Geographic Segmentation, Innovation and Future Developments Based on Research Methodology.

Inquire and Get Up to 30% DiscountBy Clicking Here!https://www.marketinforeports.com/Market-Reports/Request_discount/83332

Regions Covered in the Global Longevity and Anti-senescence Therapy Market: The Middle East and Africa (GCC Countries and Egypt) North America (the United States, Mexico, and Canada) South America (Brazil etc.) Europe (Turkey, Germany, Russia UK, Italy, France, etc.) Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

Years Considered to Estimate the Longevity and Anti-senescence Therapy Market Size:History Year: 2015-2019Base Year: 2019Estimated Year: 2020Forecast Year: 2020-2024

Highlights of the Report: Accurate market size and CAGR forecasts for the period 2019-2024 Identification and in-depth assessment of growth opportunities in key segments and regions Detailed company profiling of top players of the global Longevity and Anti-senescence Therapy market Exhaustive research on innovation and other trends of the global Longevity and Anti-senescence Therapy market Reliable industry value chain and supply chain analysis Comprehensive analysis of important growth drivers, restraints, challenges, and growth prospects

For More Information:https://www.marketinforeports.com/Market-Reports/83332/Longevity-and-Anti-senescence-Therapy-market

Customization of the Report:Market Info Reports provides customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Get Customization of the [emailprotected]:https://www.marketinforeports.com/Market-Reports/Request-Customization/83332/Longevity-and-Anti-senescence-Therapy-market

Contact Us:Mr. Marcus KelCall: +1 415 658 9988 (International)+91 84 839 65921 (IND)Email: [emailprotected]Website: http://www.marketinforeports.com

More:
COVID-19 Update: Global Longevity and Anti-senescence Therapy Market is Expected to Grow at a Healthy CAGR with top players CohBar, TA Sciences, Unity...

Read More...

Chinese Company Linked To Tesla Says It Is Ready To Start Making Million-Mile EV Battery – Forbes

June 10th, 2020 6:48 pm

Electric motor on a Tesla Model X full electric car chassis demonstration model on display at ... [+] Brussels Expo in Brussels, Belgium. The platform is fitted with the electric motors for the rear and front wheels and shows the empty space in the middle where the battery packs are fitted on the production models. (Photo by Sjoerd van der Wal)

Concern over the longevity of the batteries powering Tesla electric cars seems to waning as the stock price pushes ever higher, and the Californa-based (for now) carmaker may soon offer drivers even more security in the form of a battery that will last for over a million miles worth of driving.

Chinese battery maker Contemporary Amperex Technology, better known as CATL, which inked a supply deal with Tesla in February, claims it is ready to produce a new battery that will likely outlast an owners time with the car - a situation that has ramifications beyond just driving on electricity.

To be clear, CATLs battery tech doesnt give drivers a million miles on a single charge (that day is still a ways off), rather, the company claims that the battery will work for over 1.2 million driven miles over the course of sixteen years, or about 75,000 miles a year. Driving range will ultimately be determined by the size of the battery pack fitted to the car, but current Tesla models are giving drivers between 250 and 390 miles of range before needing a recharge. depending on configuration and model.

Most car owners in the U.S. drive their cars less than 20,000 miles per year on average. According to the BBC, most EV makers currently warranty their batteries for 60,000 to 150,000 miles.

CATL says it has a two-year contract with Tesla to start putting the new battery in Model 3 units. Terms of the contract were not specified. A company spokesperson told Bloomberg that they stand ready to begin production pending any orders they receive and that the new battery will be a 10% premium over their regular offerings. The BBC reports that CATL is looking to start producing batteries at a plant to be constructed near the German town of Erfurt in 2021. Tesla is also building a new Gigafactory in Germany and hopes to have it up and running in 2021. CATL also indicated they will offer the new batteries to car companies besides Tesla.

After The Car

While a million mile battery sounds impressive, its unlikely that a large number of electric car owners will ever drive their vehicle that distance, and in time, the rest of the vehicle may end up as unusable due to wear and tear, accidents or other service-ending reasons. At the point, the still-useful battery could find service in another role - or possibly in another vehicle as a used electric vehicle market begins to form. The batteries could also be repurposed as home energy storage units or as part of a large-scale battery array that provides power to a community or as power backup for a remote hospital.

The Electric Achilles Heel - For Now

Electric cars (and soon: trucks) continue to gain in popularity, with the now-obvious benefits of impressive performance, quiet operation, less maintenance and low operational costs becoming selling points. But the key component of electric vehicles - the battery - still needs to overcome several hurdles before it can compete squarely with gas-driven machines. Battery costs, charging times, capacity and longevity remain challenging technological problems, and while those problems will likely be solved in the next decade or so, the companies that can up with the solutions stand to reap enormous rewards as all sectors of transportation begin to shift away from fossil fuels. The quest for ever better batteries is driving research and innovation at numerous companies around the globe, with an almost unlimited market as the prize. CATLs battery tech is yet another possible step towards that eventual future.

Want to comment? I post my articles on Twitter, my Facebook page and LinkedIn posts page. Im always interested in your feedback. Thanks for reading and please click Follow below to see new articles when they are posted on Forbes.com.

Go here to see the original:
Chinese Company Linked To Tesla Says It Is Ready To Start Making Million-Mile EV Battery - Forbes

Read More...

Council resumes meetings open to the public – Portsmouth Daily Times

June 10th, 2020 6:48 pm

PORTSMOUTH Portsmouth City Council met Monday for their first meeting open to the press and public since COVID-19 precautions were established in March.

Council members and those present still practiced social distancing while the meeting took place at the Shawnee State University Ballroom. Council dispensed of the reading of the journal for May 26 and excused the absent member of council Tom Lowe.

From the legislative portion of the meeting council passed for first reading an ordinance enacting a new Chapter entitled Discrimination Prohibited, of the Codified Ordinances of the City of Portsmouth establishing a procedure to protect and safeguard the right and opportunity of all persons to be free from all forms of discrimination, including discrimination based on age, race, color, creed, religion, national origin, ancestry, disability, marital status, gender, gender identity or expression, sexual orientation, or physical characteristics and an ordinance amending Section 125.03 (K) Procedures to Determine the Lowest and Best Bid for Construction of Public Improvements of the Codified Ordinances of the City of Portsmouth, Ohio, an Ordinance amending Chapter 171- Fair Housing Practices of the Codified Ordinances of the City of Portsmouth, Other items passed for their respective readings included an Ordinance amending Chapter 171- Fair Housing Practices of the Codified Ordinances of the City of Portsmouth, and an ordinance amending Section 541.08 Ethnic Intimidation of the Codified Ordinances of the City of Portsmouth.

An Ordinance authorizing approval of the consent legislation submitted by Ohio Department of Transportation (ODOT) determining the need for a guardrail project to update Type A end treatments along NHS routes within the corporation limits of Portsmouth and an ordinance authorizing the acceptance of the United States Department of Justice, Office of Justice Programs, Bureau of Justice Assistance funding, under the Edward Byrne Memorial Justice Assistance Grant (EBMJAG) to establish a dedicated account for this grant and to authorize the appropriation of such funding as received, and an ordinance authorizing the acceptance of the United States Department of Justice, and An Ordinance authorizing the employees in the positions of Police Chief and Fire Chief be afforded the same rates for longevity as bargaining unit members within the respective departments were each waived of the three reading rule and were passed by council.

An item added to the agenda to amend the salary ordinance as amended by ordinance no. 87 of 2019 to reflect a 2.75% wage increase for FOP lodge no. 33 and a 2.5% for ASME local 1039 received as of Jan. 1 2020 a 2.75% wage increase retroactive to Jan. 1 2020 for nonunion employees longevity increases to nonunion employees as authorized per ordinance no. 66 of 2017, the addition of parks of recreation director per ordinance no. 71 of 2019 and a wage increase for position of police chief as per 2020 budget ordinance no. 7 and repeal ordinance no. 87 of 2019 was also passed for a first reading by council.

During statements and remarks from citizens regarding items not on the agenda, Sharon Bender addressed council in regards to the death at the Scioto County Jail. Bender said that although the issue is that of the county, people arrested by the Portsmouth Police also go to the jail. There are a lot of questions that need answered, and I think all people within the city of Portsmouth should be concerned that a man has died. I dont really know how more too express other than I think there are irregularities in the photos Ive seen of the man, said Bender. Bender stated that everyone in Portsmouth should be concerned because there is potential for family members of anyone in Portsmouth to find themselves at the jail and that we must demand answers and for the situation to be further addressed. Carrie Duncan also addressed council and voiced her concerns for systematic racism, calling on members of council to use their positions to promote unity.

During his Mayors report, Councilmen Johnson suggested that council be given each a copy of Ms. Duncans questions to answer during next meetings conference in order to follow Sunshine Laws.

Reach: Ivy Potter (740) 353-3101 Extension 1932

2020 Portsmouth Daily Times, all rights reserved

Follow this link:
Council resumes meetings open to the public - Portsmouth Daily Times

Read More...

Fans Claim Queen Elizabeth and Prince Philip Posted a Fake Photo for His Birthday – Showbiz Cheat Sheet

June 10th, 2020 6:48 pm

Celebrities and public figures using Photoshop is a common occurrence. But when its Queen Elizabeth accused of sharing altered photos, its sure to raise a few eyebrows.

The photo in question got posted to the official British royal family Instagram account on June 10 in honor of Prince Philips 99th birthday. Its a milestone birthday even by royal family standards and theyre known for longevity.

The picture of the queen and Philip standing outside Windsor Castle is making rounds on social media not because the Duke of Edinburgh turned 99, but rather because many royal fans are saying its a total fake.

Part of the reason the photo became instantly popular is that Her Majesty and Prince Philip dont take many photos together anymore, especially after the Duke of Edinburgh retired from his public duties in 2017. The picture is the first glimpse of Prince Philip since he was spotted leaving a London hospital on Christmas Eve 2019.

Meanwhile, Queen Elizabeth is still very active in public life and ruling even during the current global pandemic.

At first glance, the Duke of Edinburghs birthday snapshot looks totally normal. He and Queen Elizabeth are standing on the lush, green lawn of Windsor Castle where she and her husband have been holed up since quarantine guidelines became mandatory.

But upon closer inspection, fans are noticing that theres somethingstrange about the picture. Theyre saying it looks like a bad Photoshopattempt.

Look at [the queens] hands its clearly photoshopped. I havea feeling they werent even physically together for this photo, one Facebook userin a royalfamily fan group shared. The more I look at it the more I can see what is wrong withthe photo, another agreed.

The main complaint about the photo is that the shadows on Queen Elizabeth and Prince Philip dont match the sunny background, giving it an odd appearance that seems fake. Could it be that the photo was taken in front of a green screen with the backdrop added later? Maybe.

My guess is that they took the picture indoors and thensuperimposed it over the outdoors of Windsor Castle. Either that or its somesort of 3D photo, one commenter explained.

Others claim the couple looks too healthy in the picture. They are too young in that pic. He is much more frail, another person said. Am I the only one who thinks he had his jacked padded to appear healthier? one follower wondered. Philips hair looks touched up too! added another.

Between the global pandemic and civil unrest, people are feeling very nervous all around the globe. The royal family released the photo partly to celebrate the Duke of Edinburghs birthday and partly to remind the United Kingdom that Her Majesty is still working and still in charge.

Photoshoppedor not, its a lovely photo and positive gesture from the royals.

Read the original here:
Fans Claim Queen Elizabeth and Prince Philip Posted a Fake Photo for His Birthday - Showbiz Cheat Sheet

Read More...

LETTER TO THE EDITOR | Sunday was just the beginning – The Auburn Plainsman

June 10th, 2020 6:48 pm

We are Auburn Students and Community for Change. The purpose of the protest on Sunday, June 7, was to amplify the call to justice for the murder of George Floyd, Breonna Taylor, Tony McDade and the countless Black people who have lost their lives at the hands of police brutality.

We are heartbroken and enraged for every community that has lost someone to the cruelty of both the police and the systems that consistently and unremorsefully uphold the polices reign over Black lives.

Auburn Students and Community for Change would like to thank everyone for attending Sunday's protest and standing in solidarity with the Black community.

We would also like to extend our appreciation to the many people that have contributed to and supported the protest that were unable to be present with us. Your support does not go unnoticed.

Even though the protest on Sunday has ended, the Black Lives Matter movement and Auburn 4 Changes protest against police brutality, discrimination, and racism does not end here. If you care about this movement, we challenge you to take action every day to educate yourself and support organizations working toward equity and justice.

To our Allies:

Get comfortable with being uncomfortable as you stand in solidarity, advocate, and uplift Black voices within our community!

Please stop looking to Black people to fill voids in your knowledge about social and criminal injustice. You have the world wide web to educate yourself. Use it, and in turn, educate your non-Black peers.

Please continue or start calling out your friends, family, coworkers and professors making racist remarks or discriminating against minorities. You have the power to hold your city and University accountable, and to bring about drastic structural change.

By not speaking up you show that you agree. Continue to have discussions with Black people and practice Cultural Humility above all.

To the Black community:

Our voices will no longer be silenced! Our presence will be felt!

This is not a sprint but a marathon. We must continue to support each other and not give space to those who try to create division within our community.

Continue educating yourselves and finding where and how you can contribute to our movement.

We have a long history of Black liberationism and organizing to draw from, and our current mental health is also key for the longevity of our movement, locally and worldwide. Please continue to allow yourself to feel angry and demand change. It is time people are held accountable.

Lastly, remember why we all march. Remember what we fight for.

Yes, we fight for an end to police violence in the Black community. But even more, we fight against the insidious system of racism and oppression that gave rise to the violent policing culture that has existed so long. The insidious system upon which America, this state, and this city were built, and which must be dismantled to bring about a liberated world for all.

We fight against these systems so our children, and their children and their children after that can live in an America that is true to the values it has so long espoused.

The protest on Sunday has ended, but it was just one event. We ask: what are you doing today to combat systems of oppression? What will you do tomorrow? We have a long road ahead of us and a lot of work to do. Lets go.

See the original post here:
LETTER TO THE EDITOR | Sunday was just the beginning - The Auburn Plainsman

Read More...

Why Derrius Guice is the key to the future of the Redskins offense – ClutchPoints

June 10th, 2020 6:48 pm

When Derrius Guice was selected from LSU in the second round by the Washington Redskins back in 2018, his fall from his expected draft position of the first round raised some eyebrows and led to discussions of if his off-field behavior was the cause for that fall.

While he was unable to suit up until 2019 due to a torn ACL suffered during the 2018 preseason, Derrius Guice is very much in the plans for the Redskins moving forward, and he fits perfectly into the plans for the longevity of their offense, being able to team up with quarterback Dwayne Haskins and wide receiver Terry McLaurin.

Derrius Guice suited up for five games in 2019, and even when he came back, he had to deal with incumbent RB Adrian Peterson as the bell cow back even with as long as he has been in the NFL.

Yet, with Derrius Guice coming into 2020 fully healthy, he still has to deal with a full stable of RBs looking for carries.

Besides Peterson and Derrius Guice, the team also has Stanford draftee Bryce Love (who has also dealt with ACL issues), former Seahawks scatback J.D. McKissic, former Tampa Bay Buccaneers back Peyton Barber, former Indianapolis Colts back Josh Ferguson, and rookie draftee Antonio Gibson out of Memphis. While they will most likely move forward with three to four of these backs for the regular season, nothing is promised for any of them.

Derrius Guice is the back with the most to prove on the roster, as his high draft status and pedigree should become the norm for this offense moving forward. His durability and longevity are going to be the biggest determining factors for how successful the Washington offense is this season, but if he remains healthy, he should be able to take over the starting role from Peterson and command lead-back abilities as soon as the first week of the season.

Both Haskins and McLaurin are going into their third seasons in the league, and they have been able to develop a solid rapport in the offense. While both were drafted in the same year after both having attended Ohio State University, so their chemistry was already more advanced than most rookie QB-WR combinations entering the league.

Expectations for the Redskins are low for their 20 season, as they commonly have been over the past five-plus seasons, but that element should play perfectly into the accelerated development of the Redskins on both sides of the ball, but specifically on offense with Derrius Guice.

The offensive line of the Redskins is a bit in shambles, as right guard Brandon Scherff and right tackle Morgan Moses look to be the only solid and incumbent OL starters that will be able to keep Haskins upright this year, which spells disaster. Derrius Guice cant feel comfortable about that situation.

With Haskins blindside currently being protected by projected starters Geron Christian Sr. at left tackle and Wes Schweitzer at left guard, as well as Chase Roullier at center, this offense may revolve around getting the ball out of Haskins hands early in the play and not relying on long-developing route trees and plays, which would help increase Guices involvement.

In his five games last year, Derrius Guice received nine targets, seven of which he caught that went for 79 yards and one of his three touchdowns, including a long of 45 yards. A 77.8 percent catch efficiency percentage is quite high for a running back, even if it is in a vacuum.

Derrius Guice has the hands to be a multi-faceted running back that can serve as a great compliment to what Peterson has provided this team so far, which is a power back that is starting wear down and cannot command 20+ touches each and every game because of needing to keep him fresh. And while Guice cannot be brought back necessarily in full capacity right away so he can try and build up his susceptibility to injuries, it would be in the teams best interest to move forward with him as their lead back from the jump.

Haskins is 24, Derrius Guice is 22, and McLaurin is 23, which is a prime age for this team to try and take advantage of up-and-coming players on their rookie deals. For the Redskins, their defense, which has been the constant focus of early draft picks lately, like Chase Young, Daron Payne, Jonathan Allen, and Montez Sweat, is at a pretty solid spot, especially with strong safety Landon Collins having come over from the divisional rival New York Giants, so the team is now for them to try and maximize their current roster on the offensive side of the ball.

The NFC East, or the NFC Least as it is so affectionately known as, continues to give 8-8 and 7-9 teams hope on a yearly basis to be able to either win the division or sneak into the postseason as the final Wild Card team while the Redskins still project as a sub-.500 franchise for this upcoming season, their chances at progressing up the standings in the division rest very heavily on the health of Derrius Guice, albeit not fully.

Ultimately, Derrius Guice will be looked at as the two-way player that he was drafted to be, even though it has taken much longer than expected to make that kind of impact. His abilities to give the run game another option that can help with outside runs, all while providing a solid screen game/dump-off/split-out option as a receiver will help give this offense another element and if he cannot, there are other options waiting in the wings to take his spot.

Washington will not be great this year again, as their first season under new head coach Ron Rivera will help dictate the future of this franchise and which direction they are heading. For Derrius Guice, while he is no Christian McCaffrey by any means, he can help fulfill that type of role for Rivera and his offense in a way; his role may actually resemble more of what DeAngelo Williams brought to the table for the Panthers. Peterson can have the role Jonathan Stewart owned as the bigger back who was used mainly for between the tackles.

Derrius Guice is the best running back on the roster based on ceiling and potential talent alone whether he realizes and reaches that remains to be seen, but his abilities to break out will dictate the kind of future success the Redskins offense has moving forward.

Here is the original post:
Why Derrius Guice is the key to the future of the Redskins offense - ClutchPoints

Read More...

Evera, A Harvard Consumer Biotech Company, Brings Stem Cell Banking To You – Forbes

June 10th, 2020 12:47 am

Throughout the past decade, consumer biology tests have been all the rage. Companies such as 23andMe and Ancestry DNA have made their test kits accessible to every day Americans. One can screen for anomalies in their genetic code or identify their lineage. With recent advances in stem cell research, a new opportunity within the consumer biology market has appeared. Nabeel Quryshi, Michael Chen and Zeel Patel are three Harvard undergraduates who observed the unmet, rising demand of control over ones stem cells. They worked together to create Evera, the first at-home stem cell banking company. The three Harvard students are joined by the schools world-renowned biology professor, Dr. George Church. The Cambridge, Massachusetts-based company was incubated at the Harvard Innovation Lab, and has former NASA astronaut Scott Kelly as a investor.

Evera cofounders from left to right: Nabeel Quryshi, Michael Chen and Zeel Patel.

Kelly says, "I did a lot of my independent research, consulted with NASA physicians and scientists, and experts in the stem cell for cancer treatment fields. All those discussions and research indicated that this technology has merit."

Frederick Daso: What led you and your team to identify that stem cells could be potentially used to prevent neurodegenerative disease?

Nabeel Quryshi: I wouldn't single out a focus on neurodegenerative diseases. However, over the last decade, there has been a flurry of research around the use of stem cells to treat conditions such as Parkinson's, Dementia, Alzheimer's, etc. People are working on prevention, but there are two main use cases of stem cells currently. One is for treatment (replacement of damaged or lost cells), and the other is disease modeling (being able to model diseases and test the effects of new drugs completely in vitro without having to get a biopsy).

Daso: In the same ways that blood banks function, how did you manage to apply that concept to the storage of stem cells over a long time?

Quryshi: Cord blood banks and academic stem cell banks that use standardized cryopreservation protocols have been around for a while. The main innovation behind Evera was developing technology around the collection and preservation of urine-derived cells.

Daso: Why don't more mothers store their children's cord blood in stem cell banks? Is it mostly due to a price issue, or is there some other factor at play?

Quryshi: From the countless interviews we've done, it seems to be a price issue. Additionally, it's hard to make a sale around the time of birth as families have countless other things to worry about that are more immediate to the birth of a child.

Daso: What would be driving the growth of this market both now and in the future?

Quryshi: The growth of new cutting edge cell therapies is certainly further demonstrating the need for personal cell biobanking. Furthermore, the success of the direct to consumer genetic testing industry (23andMe, Ancestry, etc.) is a significant driver of growth. From the research we've conducted and the customers we have spoken to, individuals who have already taken 23andMe or another genetic test and know what they are at risk for genetically are looking for ways to take tangible action. Evera is that next step. Instead of just understanding what your future genetic risk is, Evera allows you to make a real biological investment in your future health and wellbeing. While knowing you're at risk for saying Parkinson's is excellent, being able to set aside your youngest cells so that one day you may be able to combat the effects of such a disease is terrific.

However, one should note that although the growth and technology coming from the cell therapy and stem cell therapy industry is astonishing, these are still projections. We have yet to see a fully FDA approved therapy that utilizes the specific types of stem cells we use (induced pluripotent stem cells). Nevertheless, by the time such treatments make it to the clinic, your cells will have aged significantly, and thus it makes sense to save them away now.

Daso: Could you walk me through the thought process of figuring out how to extract stem cells from urine? (From what I know, stem cells usually come from other parts of your body!)

Quryshi: Until around 2011/2012, you would have been right. However, utilizing the fantastic technology that comprised Dr. Yamanaka's 2006 Nobel Prize, scientists have been able to convert any cell in the human body to a kind of stem cell called an induced pluripotent stem cell. This cell has the capability of being able to differentiate into any cell type in the human body. We have advanced tech around the conversation of urine-derived cells to these iPSCs.

Daso: How have you designed your D2C service to ensure that a customer's DNA and associated data are not at risk?

Quryshi: We take data and privacy extremely seriously. We are well aware of the concerns people already have to D2C genetics products. To ensure the confidentiality and privacy of your data and sample, we separate your personally identifiable information from sample information and simultaneously use multiple layers of encryption and cryptography. Your sample and associated data cannot be associated with you individually. Furthermore, our facility is monitored 24/7 with top of the line security measures. We believe that your sample is your property.

Daso: What was the turning point during your undergrad to pursue this idea?

Quryshi: Having worked at 23andMe, I was able to get the lucky opportunity to be a part of arguably the world's most successful consumer genetics company. I saw first hand the benefits of providing customers with their genetic risk. Yet, I discovered that merely providing such risk predictions may not be enough led me to found Evera on the notion that tangibly investing in one's future health and wellbeing through cell banking will propel us into the age of personalized medicine.

Daso: How do you leverage your advisory board to navigate regulations and moral hazards in this space?

Quryshi: We have assembled a dream team consisting of experts in stem cell banking and cell therapy. Our co-founders and advisors comprise of professors from Harvard and Stanford, executives from companies such as Verily as well as top grad students and postdocs in stem cell biology from Harvard and Stanford. We work collaboratively to make sure we adhere to all regulations and ensure the secure preservation of our customer's cells.

If you enjoyed this article, feel free to check out my other work onLinkedInand my personal website,frederickdaso.com. Follow me on Twitter@fredsoda, on Medium@fredsoda, and on Instagram@fred_soda.

Original post:
Evera, A Harvard Consumer Biotech Company, Brings Stem Cell Banking To You - Forbes

Read More...

Cancer Stem Cell Therapy Market 2019 Break Down by Top Companies, Countries, Applications, Challenges, Opportunities and Forecast 2026 – Cole of Duty

June 10th, 2020 12:47 am

A new market report by Market Research Intellect on the Cancer Stem Cell Therapy Market has been released with reliable information and accurate forecasts for a better understanding of the current and future market scenarios. The report offers an in-depth analysis of the global market, including qualitative and quantitative insights, historical data, and estimated projections about the market size and share in the forecast period. The forecasts mentioned in the report have been acquired by using proven research assumptions and methodologies. Hence, this research study serves as an important depository of the information for every market landscape. The report is segmented on the basis of types, end-users, applications, and regional markets.

The research study includes the latest updates about the COVID-19 impact on the Cancer Stem Cell Therapy sector. The outbreak has broadly influenced the global economic landscape. The report contains a complete breakdown of the current situation in the ever-evolving business sector and estimates the aftereffects of the outbreak on the overall economy.

Get Sample Copy with TOC of the Report to understand the structure of the complete report @ https://www.marketresearchintellect.com/download-sample/?rid=237615&utm_source=COD&utm_medium=888

The report also emphasizes the initiatives undertaken by the companies operating in the market including product innovation, product launches, and technological development to help their organization offer more effective products in the market. It also studies notable business events, including corporate deals, mergers and acquisitions, joint ventures, partnerships, product launches, and brand promotions.

Leading Cancer Stem Cell Therapy manufacturers/companies operating at both regional and global levels:

Sales and sales broken down by Product:

Sales and sales divided by Applications:

The report also inspects the financial standing of the leading companies, which includes gross profit, revenue generation, sales volume, sales revenue, manufacturing cost, individual growth rate, and other financial ratios.

The report also focuses on the global industry trends, development patterns of industries, governing factors, growth rate, and competitive analysis of the market, growth opportunities, challenges, investment strategies, and forecasts till 2026. The Cancer Stem Cell Therapy Market was estimated at USD XX Million/Billion in 2016 and is estimated to reach USD XX Million/Billion by 2026, expanding at a rate of XX% over the forecast period. To calculate the market size, the report provides a thorough analysis of the market by accumulating, studying, and synthesizing primary and secondary data from multiple sources.

To get Incredible Discounts on this Premium Report, Click Here @ https://www.marketresearchintellect.com/ask-for-discount/?rid=237615&utm_source=COD&utm_medium=888

The market is predicted to witness significant growth over the forecast period, owing to the growing consumer awareness about the benefits of Cancer Stem Cell Therapy. The increase in disposable income across the key geographies has also impacted the market positively. Moreover, factors like urbanization, high population growth, and a growing middle-class population with higher disposable income are also forecasted to drive market growth.

According to the research report, one of the key challenges that might hinder the market growth is the presence of counter fit products. The market is witnessing the entry of a surging number of alternative products that use inferior ingredients.

Key factors influencing market growth:

Reasons for purchasing this Report from Market Research Intellect

Customized Research Report Using Corporate Email Id @ https://www.marketresearchintellect.com/need-customization/?rid=237615&utm_source=COD&utm_medium=888

Customization of the Report:

Market Research Intellect also provides customization options to tailor the reports as per client requirements. This report can be personalized to cater to your research needs. Feel free to get in touch with our sales team, who will ensure that you get a report as per your needs.

Thank you for reading this article. You can also get chapter-wise sections or region-wise report coverage for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

To summarize, the Cancer Stem Cell Therapy market report studies the contemporary market to forecast the growth prospects, challenges, opportunities, risks, threats, and the trends observed in the market that can either propel or curtail the growth rate of the industry. The market factors impacting the global sector also include provincial trade policies, international trade disputes, entry barriers, and other regulatory restrictions.

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage and more. These reports deliver an in-depth study of the market with industry analysis, market value for regions and countries and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Follow this link:
Cancer Stem Cell Therapy Market 2019 Break Down by Top Companies, Countries, Applications, Challenges, Opportunities and Forecast 2026 - Cole of Duty

Read More...

Stem Cell Therapy Market 2019 Break Down by Top Companies, Countries, Applications, Challenges, Trends, Opportunities and Forecast 2026 – Cole of Duty

June 10th, 2020 12:46 am

A new market report by Verified Market Research on the Stem Cell Therapy Market has been released with reliable information and accurate forecasts for a better understanding of the current and future market scenarios. The report offers an in-depth analysis of the global market, including qualitative and quantitative insights, historical data, and estimated projections about the market size and share in the forecast period. The forecasts mentioned in the report have been acquired by using proven research assumptions and methodologies. Hence, this research study serves as an important depository of the information for every market landscape. The report is segmented on the basis of types, end-users, applications, and regional markets.

The research study includes the latest updates about the COVID-19 impact on the Stem Cell Therapy sector. The outbreak has broadly influenced the global economic landscape. The report contains a complete breakdown of the current situation in the ever-evolving business sector and estimates the aftereffects of the outbreak on the overall economy.

Get Sample Copy with TOC of the Report to understand the structure of the complete report @ https://www.verifiedmarketresearch.com/download-sample/?rid=24113&utm_source=COD&utm_medium=007

The report also emphasizes the initiatives undertaken by the companies operating in the market including product innovation, product launches, and technological development to help their organization offer more effective products in the market. It also studies notable business events, including corporate deals, mergers and acquisitions, joint ventures, partnerships, product launches, and brand promotions.

Leading Stem Cell Therapy manufacturers/companies operating at both regional and global levels:

The report also inspects the financial standing of the leading companies, which includes gross profit, revenue generation, sales volume, sales revenue, manufacturing cost, individual growth rate, and other financial ratios.

The report also focuses on the global industry trends, development patterns of industries, governing factors, growth rate, and competitive analysis of the market, growth opportunities, challenges, investment strategies, and forecasts till 2026. The Stem Cell Therapy Market was estimated at USD XX Million/Billion in 2016 and is estimated to reach USD XX Million/Billion by 2026, expanding at a rate of XX% over the forecast period. To calculate the market size, the report provides a thorough analysis of the market by accumulating, studying, and synthesizing primary and secondary data from multiple sources.

To get Incredible Discounts on this Premium Report, Click Here @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=24113&utm_source=COD&utm_medium=007

The market is predicted to witness significant growth over the forecast period, owing to the growing consumer awareness about the benefits of Stem Cell Therapy. The increase in disposable income across the key geographies has also impacted the market positively. Moreover, factors like urbanization, high population growth, and a growing middle-class population with higher disposable income are also forecasted to drive market growth.

According to the research report, one of the key challenges that might hinder the market growth is the presence of counter fit products. The market is witnessing the entry of a surging number of alternative products that use inferior ingredients.

Key factors influencing market growth:

Reasons for purchasing this Report from Verified Market Research

Customized Research Report Using Corporate Email Id @ https://www.verifiedmarketresearch.com/product/Stem-Cell-Therapy-Market/?utm_source=COD&utm_medium=007

Customization of the Report:

Verified Market Research also provides customization options to tailor the reports as per client requirements. This report can be personalized to cater to your research needs. Feel free to get in touch with our sales team, who will ensure that you get a report as per your needs.

Thank you for reading this article. You can also get chapter-wise sections or region-wise report coverage for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

To summarize, the Stem Cell Therapy market report studies the contemporary market to forecast the growth prospects, challenges, opportunities, risks, threats, and the trends observed in the market that can either propel or curtail the growth rate of the industry. The market factors impacting the global sector also include provincial trade policies, international trade disputes, entry barriers, and other regulatory restrictions.

About us:

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance use industrial techniques to collect and analyse data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

Contact us:

Mr. Edwyne Fernandes

US: +1 (650)-781-4080UK: +44 (203)-411-9686APAC: +91 (902)-863-5784US Toll Free: +1 (800)-7821768

Email: [emailprotected]

Read the original:
Stem Cell Therapy Market 2019 Break Down by Top Companies, Countries, Applications, Challenges, Trends, Opportunities and Forecast 2026 - Cole of Duty

Read More...

USDA revised regulations of GMO and gene edited plants. Here’s what it means. – Genetic Literacy Project

June 10th, 2020 12:45 am

The long-awaited updates from the United States Department of Agriculture (USDA) to its genetically engineered (GE) organism regulation have been issued. This final rule completed a more than 10-year process started back in 2008 to revise regulations promulgated in 1987. This article discusses these new regulations and some of their potential impacts. Overall, the rule ignores concerns raised by some industry, consumer and environmental groups that the new regulations, including an option for developers to self-determine whether their products are regulated, and could lead to adverse environmental and/or agricultural impacts, potential food safety risks, trade disruptions and a lack of consumer acceptance of new food technologies.USDA oversight from 1987 to the present

To understand the USDAs new regulation of GE plants, it is important to know how the agency has regulated GE plants since 1987. USDA regulates the import, interstate movement, and environmental release of GE plants under its legal authority to manage plant pests under the Plant Protection Act. A plant pest is any organism that can directly or indirectly injure, cause damage to, or cause disease in any plants or plant product. Under USDA regulations, a GE plant has been considered a potential plant pest if any of its newly introduced DNA came from an organism on USDAs list of plant pests, or if the method of introducing DNA into the plants genome involved an organism on USDAs list of plant pests. For example, if a GE plant was developed using the plant pest Agrobacterium to introduce new DNA, as many are, it was regulated. However, if the same DNA were introduced using the gene-gun method of transformation, USDA would not regulate the GE plant.

Under those regulations (found at 7 CFR part 340), developers were required to submit their GE plant products to one of three oversight processes before environmental release.

The first process, known as notification, is used to regulate field trials of low-risk GE plants. The applicant provides the USDA with information detailing its trial and the agency has 30 days to decide whether to permit the trial to proceed. As many as 1,000 field trials are authorized yearly using this procedure.

The second process is permitting, which requires a more detailed application for any outdoor planting (e.g., field trial) of higher-risk GE plants. After reviewing the application, USDA may issue a permit authorizing the release. The USDA has issued hundreds of permits since 1987.

The third process involves a petition for non-regulated status, where a developer requests the USDA to determinebased on evidence from field trialsthat the GE plant presents no plant pest risk and no longer requires regulation. The petition process is the primary path to commercialization and more than 140 plants have been deregulated.

For each regulatory process, the USDA is ensuring that the GE plant is not going to become a plant pest and cause harm to agricultural interests.

Up until 2011, every GE plant tested outdoors either submitted a notification or received a permit, and all commercialized plants satisfactorily completed the petition process. Then, in 2011, the USDA established a process whereby GE seed developers could ask the agency whether the GE plants they were developing required regulation, or whether they were exempt because they did not involve any plant pest components. The USDA responded to these Am I regulated? inquiries stating whether the GE plant was not regulated and could be planted without oversight. By the end of 2019, USDA determined that more than 85 plants did not fall within its regulatory authority and are exempt from oversight. So, over the last eight years, we have seen a decrease in how many GE plants USDA regulates.[1]

The new rule (called the Sustainable, Ecological, Consistent, Uniform, Responsible, Efficient, (SECURE) Rule), which will be implemented over the next 18 months, applies to organisms produced through genetic engineering, which is defined to include techniques that use recombinant, synthesized, or amplified nucleic acids to modify or create a genome. This broad definition includes classical genetic engineering, which add one or more new genes to organism (transgenics, or what consumers consider GMOs), and newer gene editing techniques such as CRISPR, which can make edits within an organisms existing genome.

While the definition captures all GE plants, the USDA exempts many of them from any oversight. First, it exempts products with a single sequence deletion, substitution, or addition (if the addition is from the plants gene pool). Second, it exempts any GE plant that has the same plant-trait-mechanism of action as any GE plant previous regulated by the USDA. This means that if the USDA previously regulated a GE plant, such as an glyphosate-tolerant variety of corn, a new GE glyphosate-tolerant corn is exempt if it employs the same mechanism of action (meaning it biologically operates the same way to provide tolerance). Developers can self-determine whether they qualify for these exemptions; confirmation of their self-determination from the USDA is not required and the agency need not be informed.

If a GE plant is not exempt, the developer can either: (1) apply for a permit if the GE plant has potential plant pest risks; or (2) seek a Regulatory Status Review (RSR). The RSR starts with an initial 180-day process where the USDA determines if the GE plant has any plausible plant pest risks. That initial RSR step is a closer look at the GE plant than the current am I regulated? process, but less detailed than the process used for petitions for non-regulated status. The USDA stated that the initial review does not require any plant-specific laboratory or field-test data. If the USDA decides there are no plausible risks, it sends a letter to the developer stating the plant is not regulated and publishes the letter on its website. If the USDA cannot conclude that there are no plausible risks, then the developer can either: (1) request that the USDA conduct the second part of the RSR, which is detailed evaluation of potential plant pest risks that can take up to 15 month); or (2) apply for a permit. The more lengthy and detailed RSR evaluation is comparable to the current petition for non-regulated status process and ends in the USDA determining either that the GE plant is not regulated or that it needs a permit. If a developer receives a permit from the USDA, any outdoor planting (e.g. a field trial or a commercial planting) is subject to restrictions to prevent inadvertent release into the environment and any adverse plant pest impacts. These are the same restrictions that virtually all GE plants were subject to prior to 2012 under the notification and permitting processes. Only GE plants that receive permits have any continued USDA oversight.

The exemptions are one worrisome aspect of the new SECURE rule. First, they are not supported by scientific evidence showing that these categories of GE plants do not pose risks. Instead, the USDA states that since a single deletion, substitution or addition produces a plant that could be achieved by conventional breeding methods, and because conventionally bred plants have not raised plant pest risks, gene-edited plants that are the same as products that could be achieved through conventional breeding will not pose plant pest risks. The problem with this argument is that a science-based regulatory system should base its oversight on whether the plant possesses traits that make it a potential plant risks, not the plants method of production. One reason the USDA revised its rules was to focus on the properties of a product, not how it was developed, yet that is the very approach these exemptions enshrine. While many, if not most, plants with a single deletion may not present any plant pest risks, if one does, shouldnt USDA regulate it?

The second concern is that the developer self-determines if its product qualifies for an exemption. This sets up an inherent conflict of interest because developers have financial incentives to determine themselves exempt. While some developers will diligently determine the regulatory status of a GE plant, others may not. In addition, when a developer self-determines its product is exempt, neither the USDA nor the public know that the GE plant is being released into the environment and entering the food supply because there is no requirement to notify the agency of ones self-determination. If the USDA does not know which GE plants are self-determined as exempt, how can it confirm that the determination is correct?

One positive of the new rule is the agencys decision to limit the exemptions to single edits. The USDA reasons that while a single edit mimics a product that can be produced through conventional breeding methods, the same is not true for products with multiple edits. Therefore, if a developer makes two or more edits, the developer must apply for a permit or ask for an RSR. The first gene edited commercial product in the USCalyxts high oleic soybean, which the USDA exempted under the am I regulated? processwould not be exempt under the new rules because it has two edited genes. If most gene-edited products end up having two or more edits, the exemptions may have limited applicability.

While multi-edited products are not automatically exempt, the USDA is likely to find in the initial step of the RSR process that many do not pose any plausible plant pest risk. So the result may be the samethese products are not regulated. However, at least the initial RSR determination (instead of a developer self-determination), is made public, so stakeholders will know which multi-edited products are entering the market.

The USDA states that one goal of its revisions is to provide regulatory relief, and the final rule clearly achieves that. Many GE plants that historically required containment for field trials through either the notification or permitting process will no longer be subject to any substantive regulation. They either will be exempt or deemed to have no plausible plant pest risks through the initial step of the RSR process. What this means in practice is that GE plant developers (both private developers and academic scientists) can conduct field trials without any confinement conditions that ensure the GE plants do not persist in the environment after the trial is completed. The USDA stated in its proposed rule that it hopes developers voluntarily continue confinement measures, but that may or may not happen. GE plants have escaped from field trials with USDA oversight in the past and the likelihood of that happening will only increase without USDA oversight. That could mean new proteins inadvertently entering our food supply before they are deemed safe for human consumption. Experimental GE plants persisting in the environment after a field trial is concluded could also harm non-target organisms. Finally, if an unregulated GE plant escapes from a field trial and enters the export market, it could result in rejection of the US commodity because the experimental plant has not been approved in the importing country.

The final rule also fails to provide needed transparency on GE plants that will be commercialized. The USDA, food industry and consumers will be at the mercy of developers to make public information about products that they have deemed exempt. How will the food industry know which foods contain GE plants to ensure they are complying with export market legal requirements? How will food manufacturers and retailers answer questions from consumers asking whether their products contain ingredients from GE or gene-edited plants? If consumers are unable to access information about which GE plants are commercialized, will they become skeptical about those products and their safety? The lack of transparency inherent in the rule could result in international trade problems and misinformed consumers.

GE plants have provided benefits to farmers, the environment and consumers and are likely to continue to do so in the future. However, the USDA rule could impact the food industrys acceptance of those products and fuel consumer suspicions about biotech crops and foods.

[1] While the USDA is the primary agency regulating GE plants, the FDA and EPA regulate subsets of GE plants. If a GE plant is used for food or feed, the FDA regulates it under a voluntary consultation process set up under the Federal Food, Drug and Cosmetic Act. If a GE plant produces a pesticide, the EPA regulates it as a plant-incorporated protectant under the Federal Insecticide, Fungicide, and Rodenticide Act.

Original post:
USDA revised regulations of GMO and gene edited plants. Here's what it means. - Genetic Literacy Project

Read More...

Page 531«..1020..530531532533..540550..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick